APA (7th ed.) Citation

Duong, J. T., Pope, C. E., Hayden, H. S., Miller, C., Salipante, S. J., Rowe, S. M., . . . Green, N. (2024). Alterations in the fecal microbiota in patients with advanced cystic fibrosis liver disease after 6 months of elexacaftor/tezacaftor/ivacaftor. Journal of cystic fibrosis, 23(3), 490-498. https://doi.org/10.1016/j.jcf.2024.02.015

Chicago Style (17th ed.) Citation

Duong, Jennifer T., et al. "Alterations in the Fecal Microbiota in Patients with Advanced Cystic Fibrosis Liver Disease After 6 Months of Elexacaftor/tezacaftor/ivacaftor." Journal of Cystic Fibrosis 23, no. 3 (2024): 490-498. https://doi.org/10.1016/j.jcf.2024.02.015.

MLA (9th ed.) Citation

Duong, Jennifer T., et al. "Alterations in the Fecal Microbiota in Patients with Advanced Cystic Fibrosis Liver Disease After 6 Months of Elexacaftor/tezacaftor/ivacaftor." Journal of Cystic Fibrosis, vol. 23, no. 3, 2024, pp. 490-498, https://doi.org/10.1016/j.jcf.2024.02.015.